RLJ LODGING TRUST $1.95 SERIES A CUMULATIVE CONVERTIBLE PREFERRED SHARES

NYSE: RLJ-P-A (RLJ Lodging Trust $1.95 Series A Cumulative Convertible Preferred Shares)

Last update: 3 days ago, 8:08PM
Inactive

0.000

0.00 (0.00%)

Stockmoo Consensus

Strong Sell
Sell
Neutral
Buy
Strong Buy

No data within this time range.

No data within this time range.

Date Type Details
14 Jun 2024 Announcement RLJ Lodging Trust Announces Dividends for Second Quarter of 2024
10 Jun 2024 Announcement RLJ Lodging Trust Sets Dates for Second Quarter 2024 Earnings Release and Conference Call
03 Jun 2024 Announcement Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
29 May 2024 Announcement Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results
23 May 2024 Announcement Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors
23 May 2024 Announcement Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence
23 May 2024 Announcement Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence
22 May 2024 Announcement Agilent Announces Cash Dividend of 23.6 Cents per Share
22 May 2024 Announcement Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions
17 May 2024 Announcement Agilent to Participate in Jefferies Global Healthcare Conference
16 May 2024 Announcement Agilent Presents Solutions Innovation Research Awards to Cornell and Indiana University Researchers
02 May 2024 Announcement Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29
01 May 2024 Announcement RLJ Lodging Trust Reports First Quarter 2024 Results
01 May 2024 Announcement Padraig McDonnell Assumes Agilent CEO Role
01 May 2024 Announcement Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
29 Apr 2024 Announcement Agilent Names Simon May to Lead Diagnostics and Genomics Group
16 Apr 2024 Announcement Agilent Receives Scientists' Choice Awards for Sustainability
15 Apr 2024 Announcement Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
04 Apr 2024 Announcement Agilent Brings Great Science to Life at Analytica 2024
03 Apr 2024 Announcement Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
02 Apr 2024 Announcement Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
01 Apr 2024 Announcement Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data